Cairo University School of Medicine
Cairo, Egypt
NCT Number: NCT00816803
This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mesenchymal stem cells at the sites of injury promote neuronal regeneration.
Looking for future studies?
Notify Me10 year–36 year
All sexes
Interventional
Phase 1 / Phase 2
Cairo, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 18 months
Time frame: 18 months
Cairo University
Other
Autologous Bone Marrow Derived Cell Transplant in Spinal Cord Injury Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05965700
Central Nervous System Diseases, Chronic Spinal Cord Injury
Chicago, Illinois, United States
View Trial DetailsNCT06948175
Central Nervous System Diseases, Chronic Spinal Cord Injury
Edmonton, Alberta, Canada
View Trial DetailsNCT07234903
Central Nervous System Diseases, Chronic Spinal Cord Injury
Nottwil, Canton of Lucerne, Switzerland
View Trial DetailsNCT05644171
Central Nervous System Diseases, Chronic Spinal Cord Injury
Singapore
View Trial Details